Unknown NA INTERVENTIONAL 2-arm NCT01617590

Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research (DCCT)

A 48-week, Multi-center, Randomized, Open-lable, Controlled Study to Assess the Response (ACR20) Using Different Disease-Modifying Antirheumatic Drugs Cycle Combination Regimen in Adult Patients With Active Rheumatoid Arthritis

Sponsor: Shanxi Medical University

Conditions Rheumatoid Arthritis

Interventions leflunomide methotrexate

Updated 6 times since 2017 Last updated: Jun 12, 2012 Started: May 31, 2012 Primary completion: Dec 31, 2013 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01617590, this NA trial focuses on Rheumatoid Arthritis and remains ongoing. Sponsored by Shanxi Medical University, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanxi Medical University

Data source: Shanxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taiyuan, China